Back to Search
MARY EVE ZANGARI, PHD, LMFT, PMHCNS BC
PHD, LMFT, PMHCNS BC
Marriage & Family Therapist
NPI: 1245385871Individual
Specialties, Licenses & Credentials
Marriage & Family TherapistPrimary
Marriage & Family Therapist
Code: 106H00000X
MF000471(PA)
Psychiatric/Mental Health Clinical Nurse Specialist
Clinical Nurse Specialist — Psychiatric/Mental Health
Code: 364SP0808X
RN182004L(PA)
Research & Publications (20)
Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy.
PMID 19455356·Support Care Cancer·2010
3-trial
RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.
PMID 19458357·Blood·2009
7-preclinical
Bleeding disorders associated with cancer dysproteinemias.
PMID 19377931·Cancer Treat Res·2009
6-review
Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
PMID 19367157·Blood Coagul Fibrinolysis·2009
8-other
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo.
PMID 18980173·Am J Hematol·2009
7-preclinical
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
PMID 18094721·Leukemia·2008
6-review
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.
PMID 18302711·Br J Haematol·2008
2-rct
Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1.
PMID 18371114·Br J Haematol·2008
3-trial
Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.
PMID 17895401·Blood·2008
8-other
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities.
PMID 18492953·Blood·2008
3-trial
High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.
PMID 18300230·Cancer·2008
8-other
Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma.
PMID 18515882·Haematologica·2008
3-trial
Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy.
PMID 18728024·Haematologica·2008
2-rct
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma.
PMID 18432260·Leukemia·2008
3-trial
The Arkansas approach to therapy of patients with multiple myeloma.
PMID 18070718·Best Pract Res Clin Haematol·2007
6-review
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling.
PMID 18056185·Clin Cancer Res·2007
3-trial
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
PMID 18000495·Clin Adv Hematol Oncol·2007
8-other
Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients.
PMID 17890944·Blood Coagul Fibrinolysis·2007
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 115 FARLEY CIR, SUITE 105
LEWISBURG, PA 17837 - Phone
- (570) 524-0909
Quick Facts
- NPI
- 1245385871
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile